J J Larson
Overview
Explore the profile of J J Larson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lenz C, Leggett C, Katzka D, Larson J, Enders F, Alexander J
Dis Esophagus
. 2019 Mar;
32(4).
PMID: 30847465
No abstract available.
2.
Lenz C, Leggett C, Katzka D, Larson J, Enders F, Alexander J
Dis Esophagus
. 2018 Oct;
32(4).
PMID: 30295715
With the emergence of eosinophilic esophagitis (EoE) as a common cause of food impaction (FI) and a presumed increase in incidence of EoE in the population, the effect on the...
3.
Chang J, Almazar A, Richard Locke 3rd G, Larson J, Atkinson E, Talley N, et al.
Neurogastroenterol Motil
. 2018 Apr;
30(9):e13356.
PMID: 29701271
Background: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder, diagnosed on symptom-based criteria. Many have reported discrepancies between formal Rome criteria and diagnoses made in clinical practice. The...
4.
Sanford A, Schulze T, Potluri L, Hemsley R, Larson J, Judge A, et al.
Parasitol Int
. 2017 Oct;
67(2):107-111.
PMID: 29081387
We profiled three novel T. gondii inhibitors identified from an antimalarial phenotypic high throughput screen (HTS) campaign: styryl 4-oxo-1,3-benzoxazin-4-one KG3, tetrahydrobenzo[b]pyran KG7, and benzoquinone hydrazone KG8. These compounds inhibit T....
5.
Fang H, King K, Larson J, Snyder M, Wu T, Gandhi M, et al.
Aliment Pharmacol Ther
. 2017 Aug;
46(7):681-687.
PMID: 28782118
Background: Tissue transglutaminase (tTG) immunoglobulin A (IgA) testing is a sensitive adjunct to the diagnosis of coeliac disease. The threshold for positivity was developed for diagnosis, with negative results reported...
6.
Podboy A, Katzka D, Enders F, Larson J, Geno D, Kryzer L, et al.
Aliment Pharmacol Ther
. 2016 Mar;
43(11):1168-77.
PMID: 27028344
Background: To date there have been no clear features that aid in differentiating patients with eosinophilic oesophagitis (EoE) from PPI-responsive oesophageal eosinophilia (PPI-REE). However, barium swallow roentgenography is a more...
7.
Letter: role of GNβ3 polymorphisms in oesophageal adenocarcinoma and gastroesophageal reflux disease
Brummond N, Saito Y, Locke 3rd G, Larson J, Atkinson E, Romero Y, et al.
Aliment Pharmacol Ther
. 2015 Feb;
41(6):600-1.
PMID: 25659220
No abstract available.
8.
Kim H, Larson J, Lim Y, Kim W, Pedersen R, Therneau T, et al.
Am J Transplant
. 2010 Nov;
10(12):2652-7.
PMID: 21070603
Under the current allocation system for liver transplantation (LTx), primary and retransplantation (ReTx) are treated identically. The aims of this study were (1) to compare the risk of death between...
9.
Sgouros G, ODonoghue J, Larson S, Macapinlac H, Larson J, Kemeny N
Int J Radiat Oncol Biol Phys
. 1998 Aug;
41(5):1177-83.
PMID: 9719130
Purpose: Due to the cytotoxicity of DNA-bound iodine-125, 5-[125I]Iodo-2'-deoxyuridine ([125I]IUdR), an analog of thymidine, has long been recognized as possessing therapeutic potential. In this work, the feasibility and potential effectiveness...
10.
Larson J, Ball W, Bove K, Crone K, TEW Jr J
J Neurosurg
. 1998 Jan;
88(1):51-6.
PMID: 9420072
Object: Radiation is a common treatment modality for pediatric brain tumors. The authors present a retrospective review of six children who developed cerebral cavernous malformations after they underwent radiation treatment...